Michael Detamore, Ph.D.

Colorado State University’s Translational Medicine Institute welcomes Michael Detamore, Ph.D., as its next director. He joins CSU from the University of Oklahoma where he is the founding director of the Stephenson School of Biomedical Engineering (SBME). Prior to SBME, Detamore spent 12 years at the University of Kansas as a professor in the Department of Chemical & Petroleum Engineering. His primary research interest is regenerative medicine with a particular focus on translational regenerative medicine. Throughout his academic career, Detamore has demonstrated a strong commitment to student investment as well as social equity.

“I have a tremendous respect for the people I’ve worked with here,” says Detamore when explaining why he wanted to join CSU. “To me, the people you work with are so important in defining your happiness in what you do… Continue reading.

WASHINGTON, D.C.— The American Institute for Medical and Biological Engineering (AIMBE) has announced the pending induction of Michael Detamore, Ph.D., Professor, Chemical and Petroleum Engineering, University of Kansas, to its College of Fellows. Dr. Detamore was nominated, reviewed, and elected by peers and members of the College of Fellows For outstanding contributions to TMJ Bioengineering, umbilical cord Wharton’s jelly cells, and invention of multiple novel biomaterials for tissue engineering.